A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis

BACKGROUND: Amphotericin B deoxycholate (AmB-D) is standard of care treatment for neonatal invasive candidiasis (IC). Micafungin (MCA) has broad-spectrum fungicidal activity against Candida spp. We compared the efficacy and safety of intravenous MCA with intravenous AmB-D and assessed the pharmacoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Daniel K., Kaufman, David A., Hope, William W., Smith, P. Brian, Arrieta, Antonio, Manzoni, Paolo, Kovanda, Laura L., Lademacher, Christopher, Isaacson, Brigit, Jednachowski, Deborah, Wu, Chunzhang, Kaibara, Atsunori, Walsh, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2018
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155365/
https://www.ncbi.nlm.nih.gov/pubmed/29596222
http://dx.doi.org/10.1097/INF.0000000000001996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155365/
https://www.ncbi.nlm.nih.gov/pubmed/29596222
http://dx.doi.org/10.1097/INF.0000000000001996

Ejemplares similares